Decensi, A U <br/><br/>
Evidence for testicular impairment after long-term treatment with a luteinizing hormone-releasing hormone agonist in elderly men.  [electronic resource] 

 -  The Journal of urology  Nov 1989 
 - 1235-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-5347 
<br/><br/><label>Standard No.: </label>10.1016/s0022-5347(17)39042-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>17-alpha-Hydroxyprogesterone<br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Chorionic Gonadotropin<br/>Follicle Stimulating Hormone--metabolism<br/>Gonadotropin-Releasing Hormone--adverse effects<br/>Humans<br/>Hydroxyprogesterones--metabolism<br/>Luteinizing Hormone--metabolism<br/>Male<br/>Middle Aged<br/>Prostatic Neoplasms--drug therapy<br/>Testis--drug effects<br/>Testosterone--metabolism<br/>Triptorelin Pamoate